Schedule of Cumulative Effect of Changes to Condensed Consolidated Balance Sheet for Adoption of New Revenue Guidance (Detail) - USD ($) $ in Thousands |
Sep. 30, 2018 |
Jan. 01, 2018 |
Dec. 31, 2017 |
---|---|---|---|
ASSETS | |||
Accounts receivable, net | $ 2,752 | $ 2,789 | |
Deferred costs from commercial product sales | 405 | ||
Liabilities | |||
Accrued expenses and other current liabilities | 13,434 | 12,449 | |
Deferred revenue, net | 3,038 | ||
Stockholders' deficit: | |||
Accumulated deficit | (2,930,249) | $ (2,854,898) | |
Accounting Standards Update 2014-09 | |||
ASSETS | |||
Accounts receivable, net | $ 2,678 | ||
Liabilities | |||
Accrued expenses and other current liabilities | 13,098 | ||
Stockholders' deficit: | |||
Accumulated deficit | (2,853,025) | ||
Adjustment Due to New Revenue Guidance | Accounting Standards Update 2014-09 | |||
ASSETS | |||
Accounts receivable, net | 417 | (111) | |
Deferred costs from commercial product sales | 763 | (405) | |
Liabilities | |||
Accrued expenses and other current liabilities | (588) | 649 | |
Deferred revenue, net | 3,601 | (3,038) | |
Stockholders' deficit: | |||
Accumulated deficit | $ (1,833) | $ 1,873 |